The CTS also recommends targeted testing for alpha-1 antitrypsin (A1AT) deficiency in younger individuals and/or in those with worse COPD than would be expected based on their smoking history or a positive family history of A1AT deficiency (Box 1) (72). This evidence concerns the gene SERPINA1 and chronic obstructive pulmonary disease.